Search

Your search keyword '"Garrigue, Delphine"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Garrigue, Delphine" Remove constraint Author: "Garrigue, Delphine"
175 results on '"Garrigue, Delphine"'

Search Results

1. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial

2. Early hyperoxemia is associated with lower adjusted mortality after severe trauma: results from a French registry

4. Association of preoperative COVID-19 and postoperative respiratory morbidity during the Omicron epidemic wave: the DROMIS-22 multicentre prospective observational cohort study

5. Intrahospital trauma flowcharts — Cognitive aids for intrahospital trauma management from the French Society of Anaesthesia and Intensive Care Medicine (SFAR) and the French Society of Emergency Medicine (SFMU)

6. Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT)

7. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)

8. Guidelines for the acute care of severe limb trauma patients

9. Withholding and withdrawal of life-sustaining therapy in 8569 trauma patients: A multicentre, analytical registry study

12. Early management of severe abdominal trauma

13. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial

15. Prise en charge des traumatisés pelviens graves à la phase précoce (24 premières heures)

16. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)

17. Early management of severe pelvic injury (first 24 hours)

18. Strategic proposal for a national trauma system in France

19. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?

20. Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19

21. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe

22. Chest trauma: First 48 hours management

26. Association of Early Norepinephrine Administration With 24-Hour Mortality Among Patients With Blunt Trauma and Hemorrhagic Shock

27. Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion: The PROCOAG Randomized Clinical Trial.

29. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021)

30. Gunshot and stab wounds in France: descriptive study from a national trauma registry

31. Specification and Evaluation of Plasticizer Migration Simulants for Human Blood Products: A Delphi Study

32. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

33. Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study)

34. Additional file 3 of Early hyperoxemia is associated with lower adjusted mortality after severe trauma: results from a French registry

35. Additional file 2 of Early hyperoxemia is associated with lower adjusted mortality after severe trauma: results from a French registry

37. Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19

38. Erratum to “Early management of severe pelvic injury (first 24 hours)” [Anaesth Crit Care Pain Med 38 (2019) 199–207. https://doi.org/10.1016/j.accpm.2018.12.003]

40. Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study.

41. National early warning score to predict intensive care unit transfer and mortality in COVID‐19 in a French cohort.

43. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)

44. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?

45. Gestion des agents antiplaquettaires en cas de procédure invasive non programmée ou d’hémorragie. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie et de réanimation (SFAR)

48. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe

49. WITHDRAWN: Chest Trauma: First 48 hours management

50. 182 Does emergency physician prehospital management improve outcome of severe blunt trauma?

Catalog

Books, media, physical & digital resources